Prof. Dr. Yong Song, MD, PhD

Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China

Prof. Dr. Yong Song, MD, PhD, serves as a Professor and Director of the Department of Respiratory and Critical Care Medicine, Jinling Hospital, Nanjing University School of Medicine, China, where he also leads the Center of Lung Cancer at Jinling Hospital. Dr. Song received his Medical degree and PhD degree from Fourth Military Medical University and Third Military Medical University, in 1990 and 1998, respectively. From 2000 to 2002 and 2005 to 2007, he served as a Research Fellow at University of Colorado School of Medicine, Aurora, Colorado, USA. He is currently Editor-in-Chief for Translational Lung Cancer Research, and the Editorial Board of several professional journals, including the Journal of Thoracic Disease, Chinese Journal of Lung Cancer and Chinese Clinical Oncology. He has authored or coauthored more than 200 journal publications, abstracts, and book chapters.

Prof. Dr. Caicun Zhou, PhD, MD

Department of Oncology, Shanghai Pulmonary Hospital, Affiliated to Tongji University School of Medicine, Shanghai, China

Prof. Dr. Caicun Zhou, PhD, MD, is director of the Department of Oncology, Shanghai Pulmonary Hospital, director of Cancer Institute of Tongji University Medical School, chairman of the Oncology Department of Tongji University, He studied in Japan for two years and was a visiting scientist in USA for half a year. Professor Zhou is a committee member of the Chinese Association of Lung Cancer and the Chinese Society of Clinical Oncology, and is a council member of the Shanghai Anti-cancer Association, the Shanghai Pneumonology Association, and the Shanghai Oncology Association. He serves as a member on the editorial boards of many scientific journals, including ‘Tumor’, ‘Chinese-German Journal of Clinical Oncology’, ‘China Oncology’ and the ‘Chinese Journal of Clinical Oncology’ and also associate editor of Lung Cancer. Professor Zhou was selected as an ‘Excellent learning pioneer’ by the Science and Technology Commission of Shanghai Municipality (STCSM) in 2006, and got grants from the National 863 project and five other key research projects of the STCSM. His major research interests are in customized and targeted therapy of lung cancer, and he has published over 100 papers in scientific journals.

Prof. Rafael Rosell, MD, PhD

Director, Cancer Biology & Precision Medicine Program Catalan Institute of Oncology; Germans Trias i Pujol Health Sciences Institute and Hospital Badalona, Barcelona, Spain

Dr. Rafael Rosell is Head of the Molecular and Cellular Oncology Laboratory program at the Germans Trias i Pujol Research Institute and Hospital (IGTP), Campus Can Ruti, (Badalona, Barcelona, Spain), past Director of the Cancer Biology and Precision Medicine Program at the Catalan Institute of Oncology, Hospital Germans Trias i Pujol (Badalona), Chief Scientific Officer, Chairman and Founder of Pangaea Oncology SL (Barcelona), Chief Medical Officer and President of the Dr Rosell Oncology Institute (IOR), Quirón Dexeus, General de Catalunya & Sagrat Cor Univ. Hospitals (Barcelona), and Founder and President of the Molecular Oncology Research Foundation (Barcelona). He is Founder and Director of International Relations and Projects, Spanish Lung Cancer Group (SLCG), member of the Foundation Council and Steering Committee of the European Thoracic Oncology Platform (ETOP) and on the Foundation Board of the ETOP- International Breast Cancer Study Group (IBCSG). He is also a Panel member of the ASCO Clinical Practice Living Guidelines- Systemic Therapy for Stage IV NSCLC.

Dr. Rosell's contributions to translational medical oncology, with particular emphasis in the field of non-small-cell lung cancer with EGFR mutations, have earned him international renown.